Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Zoledronic Acid in Bone Metastases
NCT00434447Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2006
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in bone metastases, multiple myeloma (MM), sponsored by Novartis. Started Dec 2006; status: completed.
02
Drugs
zoledronic acid
03
Conditions
bone metastasesmultiple myeloma (MM)
Beyond the preview
Go deeper on NCT00434447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434447.